These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6136412)

  • 1. Time course of the bronchial response to salbutamol after placebo, betaxolol and propranolol.
    Palminteri R; Kaik G
    Eur J Clin Pharmacol; 1983; 24(6):741-5. PubMed ID: 6136412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of penbutolol and propranolol on normal airway response to salbutamol.
    Warren JB; Monaghan AT; Clark TJ
    Clin Pharmacol Ther; 1984 Jul; 36(1):47-50. PubMed ID: 6734048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of bronchial beta-adrenoceptor blockade in man.
    Gribbin HR; Baldwin CJ; Tattersfield AE
    Br J Clin Pharmacol; 1979 Jun; 7(6):551-6. PubMed ID: 37867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary effects of long-term beta 2-blockade in healthy subjects: comparative study of metoprolol OROS.
    Bauer K; Rakusan S; Kaik G
    Am Heart J; 1990 Aug; 120(2):473-7. PubMed ID: 1974382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG; Shanks RG
    Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of intravenously administered aminophylline on normal airways.
    Mackay AD; Baldwin CJ; Tattersfield AE
    Am Rev Respir Dis; 1983 May; 127(5):609-13. PubMed ID: 6303166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.
    Giudicelli JF; Chauvin M; Thuillez C; Richer C; Bianchetti G; Gomeni R; Morselli PL
    Br J Clin Pharmacol; 1980 Jul; 10(1):41-9. PubMed ID: 6104973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of beta-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers.
    Bauer K; Dietersdorfer F; Kaik G
    Clin Pharmacol Ther; 1993 Jun; 53(6):675-83. PubMed ID: 8099863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic function in airways of healthy and asthmatic subjects.
    Gayrard P; Orehek J; Grimaud C; Charpin J
    Thorax; 1975 Dec; 30(6):657-62. PubMed ID: 769241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of bronchial beta blockade after oral bevantolol.
    Mackay AD; Gribbin HR; Baldwin CJ; Tattersfield AE
    Clin Pharmacol Ther; 1981 Jan; 29(1):1-6. PubMed ID: 6109585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway effects of salmeterol in healthy individuals.
    Bergendal A; Johansson A; Bake B; Lötvall J; Skoogh BE; Löfdahl CG
    Pulm Pharmacol; 1995 Dec; 8(6):283-8. PubMed ID: 8819183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.
    Grove A; McFarlane LC; Lipworth BJ
    Thorax; 1995 Feb; 50(2):134-8. PubMed ID: 7701450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
    Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.
    Lipworth BJ; Brown RA; McDevitt DG
    Br J Clin Pharmacol; 1989 Jul; 28(1):95-102. PubMed ID: 2570601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia.
    Saunders J; Gomeni R; Kilborn JR; Morselli PL; Sönksen PH
    Eur J Clin Pharmacol; 1981; 21(3):177-84. PubMed ID: 6119203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].
    de Dieuleveult C; Queinnec MC; Pinaud M; Souron R
    Ann Fr Anesth Reanim; 1989; 8(1):46-50. PubMed ID: 2565697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between response to inhaled prostaglandin E2 and chronic beta-adrenergic agonist treatment.
    Walters EH; Bevan M; Davies BH
    Thorax; 1982 Jun; 37(6):430-7. PubMed ID: 7135277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.
    Cadigan PJ; London DR; Pentecost BL; Bianchetti G; Gomeni R; Kilborn JR; Morselli PL
    Br J Clin Pharmacol; 1980 Jun; 9(6):569-75. PubMed ID: 6104498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods.
    Hanratty CG; Silke B; Riddell JG
    Br J Clin Pharmacol; 1999 Feb; 47(2):157-66. PubMed ID: 10190650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.